Evidence map›Paper›PMID 33828213›Full record

ArticleScientific reports2021

Nicotinamide mononucleotide production by fructophilic lactic acid bacteria.

Kazane Sugiyama, Kana Iijima, Miyako Yoshino, Hideo Dohra, Yuji Tokimoto, Koji Nishikawa, Hideaki Idogaki, Nobuyuki Yoshida

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Effect of oral intake of heat-killedBioscience of microbiota, food and health · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Cytotechnology · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kazane SugiyamaDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamamatsu, 432-8561, Japan.
Kana IijimaDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamamatsu, 432-8561, Japan.
Miyako YoshinoDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamamatsu, 432-8561, Japan.
Hideo DohraDepartment of Science, Graduate School of Integrated Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, 422-8529, Japan.
Yuji TokimotoOsaka Soda Co., Ltd., 12-18 Awaza 1-chome, Nishi-ku, Osaka, 550-0011, Japan.
Koji NishikawaOsaka Soda Co., Ltd., 12-18 Awaza 1-chome, Nishi-ku, Osaka, 550-0011, Japan.
Hideaki IdogakiOsaka Soda Co., Ltd., 12-18 Awaza 1-chome, Nishi-ku, Osaka, 550-0011, Japan.
Nobuyuki YoshidaDepartment of Engineering, Graduate School of Integrated Science and Technology, Shizuoka University, 3-5-1 Johoku, Naka-ku, Hamamatsu, 432-8561, Japan. yoshida.nobuyuki@shizuoka.ac.jp.ORCID 0000-0002-0202-0756
Shizuoka University · JPOsaka Soda (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotinamide mononucleotide (NMN), an intermediate in nicotinamide adenine dinucleotide biosynthesis, is recently attracting much attention for its pharmacological and anti-aging efficacies. However, current commercial products containing NMN are very high-priced because efficient and facile methods for industrial NMN production are limited. In this study, aiming for its nutraceutical application, we attempted to screen lactic acid bacteria for intracellular and/or extracellular NMN production. Using a bioassay system with an auxotrophic yeast that requires nicotinamide riboside (NR; dephosphorylated NMN), three candidates were obtained from a library of 174 strains of facultative anaerobic lactic acid bacteria. All three candidates belonged to the genus Fructobacillus and produced NR in the culture media (0.8-1.5 mg/l). Lactic acid bacteria of the genus Fructobacillus are known to use D-fructose as an electron acceptor in anaerobic lactic acid fermentation; addition of D-fructose to the medium caused intracellular accumulation of NMN and NR, but no extracellular production of these compounds was observed. Draft genome sequencing for one of the candidates suggested that nicotinamide phosphoribosyltransferase, which exists commonly in mammals but is less reported in microorganisms, is a key enzyme for NMN and NR production in the fructophilic bacteria.

Indexed as

Escherichia coliFructoseLactobacillalesLeuconostocNiacinamideNicotinamide MononucleotideNicotinamide PhosphoribosyltransferasePyridinium CompoundsFructoseNiacinamidenicotinamide-beta-ribosideNicotinamide MononucleotideNicotinamide PhosphoribosyltransferasePyridinium Compounds

Identifiers

PMID33828213
PMCPMC8027369
OpenAlexW3149077290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.